Litcius/Paper detail

Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors

Hee Jin Jeong, Hye Lim Lee, Sung Joon Kim, Jeong Hyun Jeong, Su Hyun Ji, Han Byeol Kim, Miso Kang, Hwan Won Chung, Chan Sun Park, Hyunah Choo, Hyo Jae Yoon, Nam‐Jung Kim, Duck‐Hyung Lee, Sang‐Hee Lee, Seo‐Jung Han

2022Journal of Enzyme Inhibition and Medicinal Chemistry15 citationsDOIOpen Access PDF

Abstract

causes inhibition of tumour growth in 4T1 syngeneic mouse model. This study provides new insight into the designing of novel ENPP1 inhibitors and warrants further development of small molecule immune modulators for cancer immunotherapy.

Topics & Concepts

Stimulator of interferon genesStingPhosphodiesteraseIC50Cancer immunotherapyChemistrySmall moleculeInterferonImmune systemPharmacologyImmunotherapyBiochemistryBiologyIn vitroEnzymeGeneticsCytosolAerospace engineeringEngineeringinterferon and immune responsesCytokine Signaling Pathways and InteractionsProtein Tyrosine Phosphatases
Identification of novel pyrrolopyrimidine and pyrrolopyridine derivatives as potent ENPP1 inhibitors | Litcius